Member Info for DireCons

Many thanks Elric btw.

SA clearly described the dilemma he was in, and quite rightly held his hand up. If you could be bothered to watch, you would see clarification of the change of tack.

Bel, you say "Croda taking a bigger company position."

Did I miss the rns that states they took a position?

I'm still taking AxisBiotix, since the end of January. Have seen the minor itchy dry skin on my lower calves go completely pretty early on. However, the arthritic pain in my knees and right fingers is very greatly reduced. I still take naproxen, 1 a day instead of 2. Had a setback a few weeks ago when I twisted my right knee at work, but ice, rest and a steroid jab got me going again. Now back to how I was before the injury which is great.

bigpunt, did you really invest in a company without doing your dd?

https://www.skinbiotherapeutics.com/sectors/

It's a tough nut to crack. The alternative non scientific brands have had years to build up a following, whereas OPTI Slimbiome is new, and importantly, selling at a premium that people are reluctant pay, regardless of the scientific validity.
I don't know what else they can do to get a foot in the door, apart from buying their way in via a buyout of an established heath brand, but that is something that would probably need an eye watering fundraiser.

Time for the weirdo stalker to hit the bin.

"Talk about deluded self importance.This guy is a legend in his own lunchtime!
Me me me."
So, to get this straight. You are talking about yourself?

Completely missed that rns. It just shows what a drag it is to get things going.
Could be that the peer revue has helped push things forward.

Looks as though Ayalla are taking LPLDL to market/manufacturing? Did I miss the RNS?

https://ayalla.com.br/en/

With thanks to Trotters on adv and AJS, on Twitter I think.

HOWS THIS FOR PRODUCT DIFFERENTIATION!!!

Credit to AJS who found the SWEETBIOTIX peer review paper (published yesterday)

Key part..

Looks like this is the SweetBiotix paper - Published 13th July 2022 'Published by American Chemical Society' - Kolida, Rastall, et all - sponsors Optibiotix

Skim read, some extracts ??

'This study was conducted to investigate the sweetness intensity and the potential fecal microbiome modulation of galactooligosaccharides in combination with enzymatically modified mogrosides (mMV-GOS), both generated through a patented single-pot synthesis. Sweetness intensity was performed in vivo by trained sensory panelists...In conclusion, these substrates could be considered as novel candidate prebiotic sweeteners, foreseeing a feasible and innovative approach targeting the sucrose content reduction in food. This new ingredient could provide health benefits when evaluated in human studies by combining sweetness and prebiotic fiber functionality.'

'Our data have shown that mMV-GOS, obtained by the simultaneous synthesis of GOS and modified mogrosides using bacterial ß-galactosidases, can generate products with the potential to positively modulate the human fecal microbiota in vitro, generating metabolites such as propionate and butyrate that are involved in appetite regulation (47) and also in tight junction integrity and anti-inflammatory properties that play an important role in improving type II diabetes inflammation processes. The potential prebiotic activity of mMV-GOS is an added benefit in combination with the sweetness profile.'

'In conclusion, these in vitro analyses and sweet taste studies suggest that the simultaneous synthesis of modified mogrosides and GOS could exert a prebiotic functionality, which warrants further studies investigating the effects of this novel ingredient under in vivo conditions representing physiologically human-relevant exposure scenarios. In this context, these substrates could be considered as a novel candidate prebiotic sweetener by combining sweetness and prebiotic fiber functionality, providing a feasible and innovative approach to reducing the sucrose content in food products.'

https://pubs.acs.org/doi/10.1021/acs.jafc.2c01363

Can't see a problem with the photo tbh.

That's a good spot Aquae. Just shows even the big corporates are looking closely at the microbiome. Mentions Lactobacillus.

Looks as though a bounce may be sustained?

You need to get a restraining order Elrico.

It's above this chat if you scroll up. it's traded in GBP.
Share Price: 21.00
Bid: 20.00
Ask: 22.00

Toyin, I wouldn't waste any more of your precious time on the muppet show. I had 'kreature' alias 'The Dictator' sussed early days.
10k investment my ar5e. Lol!

Don't rise to the stalker Elric. Just a pathetic wind up merchant.

LOL!

Realistically, when can we buy it here in the UK though? What will it take to get this in supermarket fridges here?